Detalles de la búsqueda
1.
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
Blood
; 141(5): 534-549, 2023 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36322930
2.
Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.
Cancer Sci
; 114(8): 3461-3465, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37232264
3.
Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell proliferation.
Ann Hematol
; 98(3): 723-733, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30430191
4.
Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance.
Genes Chromosomes Cancer
; 57(11): 547-556, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30248204
5.
R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY.
Cancer Sci
; 109(9): 2830-2840, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29957865
6.
Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Int J Mol Sci
; 19(9)2018 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30142940
7.
[Human herpesvirus-6 pneumonitis following autologous peripheral blood stem cell transplantation].
Rinsho Ketsueki
; 59(3): 300-304, 2018.
Artículo
en Japonés
| MEDLINE | ID: mdl-29618688
8.
Phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome.
Cancer Sci
; 108(12): 2445-2453, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28949050
9.
Genetic variants in C5 and poor response to eculizumab.
N Engl J Med
; 370(7): 632-9, 2014 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24521109
10.
BCR-ABL1-positive chronic myeloid leukemia emerging in a patient with secondary myelofibrosis harboring the JAK2-V617F mutation.
Rinsho Ketsueki
; 58(4): 298-302, 2017.
Artículo
en Japonés
| MEDLINE | ID: mdl-28484156
11.
Exosomes promote bone marrow angiogenesis in hematologic neoplasia: the role of hypoxia.
Curr Opin Hematol
; 23(3): 268-73, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26866730
12.
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood
; 124(25): 3748-57, 2014 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25320245
13.
Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib.
Int J Mol Sci
; 17(4): 570, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27092489
14.
Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.
Genes Chromosomes Cancer
; 54(12): 809-17, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26355708
15.
Musculoskeletal pain after stopping tyrosine kinase inhibitor in patients with chronic myeloid leukemia: a questionnaire survey.
Rinsho Ketsueki
; 57(7): 873-6, 2016 07.
Artículo
en Japonés
| MEDLINE | ID: mdl-27498732
16.
Very late relapse with rapid BCR-ABL1 elevation after more than seven years of treatment-free remission with undetectable molecular residual disease in chronic myeloid leukaemia.
Br J Haematol
; 188(2): 332-334, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31702048
17.
Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma.
Haematologica
; 105(7): e337-e339, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31699793
18.
Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group.
Haematologica
; 100(2): 205-13, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25344522
19.
Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group.
Am J Hematol
; 90(4): 282-7, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25530131
20.
Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D-first study.
Am J Hematol
; 90(9): 819-24, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26103598